Quanta, Inc.

Quanta, Inc.

QNTA
Quanta, Inc.US flagOther OTC
0.00
USD
- -
- -
40,659.00Market Cap
Quanta, Inc.
QNTA
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Quanta, Inc. (Nasdaq: QNTA) operates as an e-commerce platform specializing in consumer health and wellness products. The company offers a wide range of supplements, vitamins, and nutritional aids through its BuyQuanta.com website, including branded categories such as immune support, joint health, digestive wellness, and performance enhancers; it also provides subscription-based delivery services, personalized recommendation tools, and bundled product kits tailored for fitness enthusiasts, seniors, and families. Quanta serves retail customers primarily in North America, with expanding operations into Europe and Asia via international shipping partnerships. Founded in 2018 and headquartered in Austin, Texas, the company focuses on direct-to-consumer sales in the health supplements industry, targeting health-conscious individuals and wellness retailers. In late 2024, Quanta announced a strategic rebranding initiative to unify its product lines under a streamlined brand identity, alongside a major funding round exceeding $50 million to fuel expansion into AI-driven personalization services and new product launches in sustainable, plant-based nutraceuticals. This follows its 2023 acquisition of a complementary vitamin formulation subsidiary, enhancing its manufacturing capabilities and supply chain resilience.

Company News

  • Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

  • Quanta Services Announces Quarterly Cash Dividend

  • Quanta's Net Income Nearly Doubles: Can Profit Growth Stay Hot?

  • Quanta vs. Jacobs: Which Infrastructure Stock is the Better Buy Now?

  • Is Quanta Becoming the Biggest Winner From America's AI Buildout?

  • Quanta Services: Recent Selloff Creates Compelling Buy

  • Is Quanta's Capital Strategy Creating More Than Earnings Growth?

  • Quanta Lifts FCF Outlook to $2-$2.5B: Can Conversion Keep Improving?

  • Quanta Computer and Quantinuum Partner to Build an Industrial Foundation for Large-Scale Quantum Computing

  • Quanta Stock Descends 14% in Past 3 Months: Should You Buy Now?

  • Is Quanta's Raised 2026 Outlook Just the Start of a Bigger Story?

  • How Quanta's Raised 2026 Outlook Could Reshape Its Growth Story Ahead

  • Quanta Services Announces Pricing of Senior Notes Offering

  • Quanta Services: The Market Compressed The Multiple And Not The Thesis

  • Quanta Services Q2 Earnings Call Highlights

  • Quanta Services Q2 Earnings Call Highlights Growth & Backlog Strength

  • Quanta Computer seeks up to $2.2 billion in GDS sale

  • Quanta Before Q2 Earnings: Should You Buy, Sell or Hold the Stock Now?

  • Can Quanta's Execution Certainty Strengthen Its Competitive Position?

  • Quanta Services Named 2026 Top U.S. Solar Solutions Provider by Solar Power World